When is OGTR (Office of the Gene Technology Regulator) approval likely required, according to the TGA?

Question

BlackTom AI · Accepted Answer

OGTR oversight applies whenever genetically modified organisms (GMOs) are involved in the development, manufacture or use of therapeutic goods — so approval is required for medicines that contain GMOs, medicines that consist of GMOs, and products manufactured in Australia that are derived from GMOs.

1. Relevant knowledge points and concepts
- The Office of the Gene Technology Regulator (OGTR) regulates dealings with GMOs in Australia (containment, use, release).
- The Therapeutic Goods Administration (TGA) refers to OGTR when a therapeutic product involves GMOs: this includes (a) medicines that contain GMO material, (b) medicines that consist of GMOs (e.g., live gene therapy vectors or GMO cells), and (c) medicines manufactured in Australia that are derived from GMOs (manufacturing activities with GMO material typically require OGTR assessment and approval).

2. Step-by-step reasoning
- Option (a): If a medicine contains a GMO (even as a component), that triggers OGTR considerations because the product includes a regulated organism.
- Option (b): If a medicine consists of GMOs (the active substance is itself a GMO, such as a viral vector or modified cell therapy), OGTR oversight is clearly required.
- Option (c): If manufacturing occurs in Australia and uses GMO-derived material, the activity is a “dealing” with GMOs within the OGTR remit and usually requires licence/approval.
- Because each of the above scenarios independently triggers OGTR involvement, the comprehensive correct choice is that all apply.

3. Calculations
- None required.

4. Why the correct answer is correct
- OGTR’s statutory remit is defined by the presence or use of GMOs; any product or process that meets those criteria will likely need OGTR approval. The three answer choices enumerate distinct, but overlapping, ways a medicine can involve GMOs — each falls under OGTR jurisdiction.

5. Why the other options are incorrect
- (a), (b) and (c) are each true statements but incomplete: they describe specific circumstances. Choosing any single one ignores the other situations where OGTR approval would also be needed.

6. Conclusion
- Therefore the correct answer is d. All of the above, which matches the provided answer.

When is OGTR (Office of the Gene Technology Regulator) approval likely required, according to the TGA?单项选择题

类似问题

Biosafety of gene technology is regulated through:

Question at position 8 An excess of growth hormone (GH) before puberty can result in the development ofgigantism.Graves' disease.acromegaly.pituitary dwarfism.Clear my selection

Question at position 6 The most abundant supporting cells in the central nervous system are called Question Blank 1 of 1[input].

Question at position 5 In the eye, the lens functions tofocus light on the retina at the back of the eye.protect the surface of the eye.increase vision in low-light conditions.move the eye side to side.Clear my selection

Question at position 4 Olfactory (odor) receptors are chemoreceptors. TrueFalse

If the pKa of HCHO2 is 3.74 and the pH of an HCHO2/NaCHO2 solution is 3.00, which of the following is TRUE?

Identify the missing particle in the following nuclear equation: 92 236 𝑈 → 38 90 𝑆 𝑟 + ? + 2 0 1 𝑛 + 4 0 0 𝑔

Which type of radioactivity will affect the mass of the isotope the least?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单